Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Integrated Biopharma Inc (INBP)

Integrated Biopharma Inc (INBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,522
  • Shares Outstanding, K 30,100
  • Annual Sales, $ 50,320 K
  • Annual Income, $ 110 K
  • 60-Month Beta 0.67
  • Price/Sales 0.14
  • Price/Cash Flow 5.64
  • Price/Book 0.39
Trade INBP with:
  • Price/Earnings ttm 22.80
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings $0.01 on 09/20/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1735 +44.03%
on 09/03/24
0.2499 unch
on 09/23/24
+0.0499 (+24.95%)
since 08/16/24
3-Month
0.1638 +52.56%
on 08/15/24
0.2499 unch
on 09/23/24
+0.0267 (+11.96%)
since 06/12/24
52-Week
0.1638 +52.56%
on 08/15/24
0.2990 -16.42%
on 10/10/23
-0.0201 (-7.44%)
since 09/22/23

Most Recent Stories

More News
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2024

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024

HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023

HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023

HILLSIDE, NJ / ACCESSWIRE / May 11, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2023.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022

HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022

HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022

HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022.

INBP : 0.2499 (+9.61%)
Integrated BioPharma Announces Change in Directors

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board...

INBP : 0.2499 (+9.61%)

Business Summary

Integrated BioPharma, Inc. is a well-established biopharma company serving the varied needs of the nutraceutical, biotech and pharmaceutical industries. Through a number of wholly owned subsidiaries INB develops, manufactures and distributes, worldwide over 130 products.

See More

Key Turning Points

3rd Resistance Point 0.2764
2nd Resistance Point 0.2632
1st Resistance Point 0.2565
Last Price 0.2499
1st Support Level 0.2366
2nd Support Level 0.2234
3rd Support Level 0.2167

See More

52-Week High 0.2990
Last Price 0.2499
Fibonacci 61.8% 0.2474
Fibonacci 50% 0.2314
Fibonacci 38.2% 0.2154
52-Week Low 0.1638

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar